Fig. 1. Immunohistochemistry and histopathological evaluation reveal AKR1B10 expression and specific morphological features in FH-proficient leiomyomas.
a 2SC and AKR1B10 antibodies can both act as biomarkers for FH-deficiency. Immunohistochemistry showed strong staining with both antibodies in FH-deficient tumors. It also revealed a subgroup of tumors positive only for AKR1B10 (AKR1B10hi). Histopathological evaluation of the AKR1B10hi tumors showed increased cellularity in most of them. Myometrium was negative for both AKR1B10 and 2SC. b Half of the AKR1B10hi tumors showed two or more features associated with FH-deficiency [37], including eosinophilic inclusions (top left), staghorn vasculature (top right), eosinophilic nucleoli and nuclear atypia (bottom left), and alveolar edema (bottom right). Example of eosinophilic nucleoli is marked with an arrow. c Half of the AKR1B10hi samples displayed perivascular hypercellularity, a feature not associated with leiomyomas previously. Magnification 100× (left) and 200× (right).